SCHEMBL2819482

SCHEMBL2819482

COC(=O)C1CN(C(=O)c2cc(F)ccc2C(F)(F)F)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
HCRTR1 O43613 2/20 0.45
HCRTR2 O43614 2/20 0.45
SCD O00767 1/20 0.40
EPHX2 P34913 1/20 0.40
WNT3 P56703 2/20 0.39
SFRP1 Q8N474 2/20 0.39
PTPN1 P18031 1/20 0.38
CCR3 P51677 1/20 0.38
CPS1 P31327 1/20 0.37
HSD11B1 P28845 1/20 0.37
MCL1 Q07820 1/20 0.37
SMO Q99835 1/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
SETD7 Q8WTS6 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224423 0.82 GPR119 (0.49) HCRTR1HCRTR2SCDEPHX2TP53
SCHEMBL2817774 0.79 HCRTR1 (0.48) HCRTR1HCRTR2SCDSMO
Hydrochloric Acid SCHEMBL2817771 0.78 HCRTR1 (0.48) HCRTR1HCRTR2SCDSMO
SCHEMBL1849268 0.76 NR1H2 (0.54) NR1H2NR1H3EPHX2PTPN1SETD7
SCHEMBL919744 0.76 NR1H2 (0.54) NR1H2NR1H3EPHX2PTPN1SETD7
SCHEMBL282661 0.76 NR1H2 (0.54) NR1H2NR1H3EPHX2PTPN1SETD7
SCHEMBL17748964 0.75 NR1H2 (0.63) NR1H2NR1H3PTPN1
SCHEMBL28060561 0.74 NR1H2 (0.53) NR1H2NR1H3EPHX2PTPN1SETD7
SCHEMBL716249 0.73 CCNT1 (0.40) NR1H2NR1H3EPHX2PTPN1HSD11B1
SCHEMBL5935437 0.73 GPR119 (0.49) HCRTR1HCRTR2SCDSMOTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010075356-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-07-01 WO disclosed
US-20100160323-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-06-24 US disclosed
US-20100160323-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160323-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 NR1H2 131/4885NR1H3 184/4885HCRTR1 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.